Risk stratification in non-muscle-invasive bladder cancer in the era of expanding therapeutic options: Are current classifications still adequate?. // The French Journal of Urology. – URL: https://www.sciencedirect.com/science/article/pii/S2950393026001312?dgcid=rss_sd_all
Risk stratification in non-muscle-invasive bladder cancer in the era of expanding therapeutic options: Are current classifications still adequate?. The French Journal of Urology. https://www.sciencedirect.com/science/article/pii/S2950393026001312?dgcid=rss_sd_all
“Risk stratification in non-muscle-invasive bladder cancer in the era of expanding therapeutic options: Are current classifications still adequate?.” The French Journal of Urology.
@article{article95358,
title = {Risk stratification in non-muscle-invasive bladder cancer in the era of expanding therapeutic options: Are current classifications still adequate?},
journal = {The French Journal of Urology},
url = {https://www.sciencedirect.com/science/article/pii/S2950393026001312?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...